Synthesis of new 1,2,4-triazole derivatives of nalidixic acid as potential antibacterial and antifungal agents

Bulletin of Pharmaceutical Sciences

Volumn 32, Issue PART 1, 2009, Pages 125-140

  Abdelmoty, Samia G ^a   Heta, Helal F ^b  

^a Assiut University   (Egypt)

^b Assiut University Faculty of Medicine   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,4 TRIAZOLE DERIVATIVE; ALDEHYDE; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZYL CHLORIDE; CLOTRIMAZOLE; ESTER; FUSED HETEROCYCLIC RINGS; HALIDE; HYDRAZIDE; HYDRAZINE; NALIDIXIC ACID; POTASSIUM; SCHIFF BASE; TRIAZOLE;

AGRICULTURE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; IN VITRO STUDY; INDUSTRY; NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EID: 77949488014     PISSN: 11100052     EISSN: None     Source Type: Journal    
DOI: 10.21608/bfsa.2009.63350     Document Type: Article

References (28)

1. G. Gaurav and S.G. Kini, Eur. J. Med. Chem., 41, 256 (2006).
2. R. Albrecht, Prog. Drug Res., 21, 9 (1977).
3. M. I. El-Zahar, M. M. Kamel and E. M. Mohei El-Deen, Egypt. J. Chem., 45, 323 (2002).
4. R. A. Mekheimer, A. M. Abdel Hameed and K. U. Sadek, Arkivoc, (xiii), 269 (2007).
5. A. S. Noravyan, E. G. Paronikyan and S. A. Vartanyan, J. Pharm. Chem., 19, 439 (1985).
6. G. Gaurav and S. G. Kini, Indian J. Heterocycl. Chem., 12, 289 (2003).
7. A. F. Youssef, F.A. Omar, H. A. Elsherief and G. E. A. Abuo-Rahma, Bull. Pharm. Sci., Assiut University, 21, 15 (1998).
8. A. M. Sugar, X. P. Liu and R. J. Chen, Antimicrob. Agents Chemother., 41, 2518 (1997).
9. Y. A. Al-Soud and N. A. Al-Masoudi, J. Braz. Chem. Soc., 14, 790 (2003).
10. Y. He, J. Yang, B. Wu, L. Riesen and E. Swayze, Bioorg. Med. Chem. Lett., 14, 1217 (2004).
11. K. C. Ragenovic, V. Dimova, V. Kakurinov, D. G. Molnar and A. Buzrouska, Molecules, 6, 815 (2001).
12. R. M. Shaker and A. A. Aly, Phosphorus, Sulfur, and Silicon, 181, 2577 (2006).
13. N. F. Eweiss, A. A. Bahajaj and E. A. Elsherbini, J. Heterocycl. Chem., 23, 1451 (1986).
14. G. Grossi, M. Di Braccio, G. Roma, V. Ballabeni, M. Tognolini and E. Barocelli, Eur. J. Med. Chem., 40, 155 (2005).
15. F. A. Omar, Alex. J. Pharm. Sci., 8, 65 (1994).
16. G. A. A. Abuo-Rahma, Master Thesis, Assiut University, Assiut, Egypt (1998).
17. M. G. Mamolo, V. Falagiani, D. Zampieri, L. Vio, and E. Banfi, Farmaco, 56, 587 (2001).
18. A. Foroumadi, S. Emami, A. Hassanzadeh, M. Rajaee, K. Sokhanvar, M. H. Moshafi and A. Shafiee, Bioorg. Med. Chem. Lett., 15, 4488 (2005).
19. A. M. Clark, F. S. El-Feraly and W. Li, J. Pharm. Sci., 70, 951 (1981).
20. A. Felten, B. Grandly, P. H. Lagrange and I. Casin, J. Clin. Microbiol., 40, 2766 (2002).
21. rd Ed. (Churchill Livingstone) London, New York, Vol. 2, 1989, pp. 161-289.
22. W. Hewitt, "Microbiological Assay, An Introduction to Quantitative Principles and Evaluation", (Academic press) New York, London, 1977, pp. 17-69.
23. M. A. El-Sherbeny, M. B. El-Ashmawy, A. A. El- Subbagh and F. A. Badria, Eur. J. Med. Chem., 30, 445 (1995).
24. M. Biagini C., F. Bigoli, M. Lanfranchi, E. Leporati, M. Angela P. and C. Foglia, Inoganica Chimica Acta, 235, 37 (1995).
25. D. M. Smith, In "Chemistry of Heterocyclic Compounds", 40, I, Weissberger, A., editor, John Wiely and Sons, New York, 1981, p. 360.
26. N. N. Gülerman, N. H. Doöan, S. Rollas, C. Johansson and C. Celik, Farmaco, 56, 953 (2001).
27. C. A. Michels, J. Blamire, B. Goldfinger and J. Marmur, Antimicrob. Ag. Chemother., 3, 562 (1973).
28. S. Ahmed, M. H. Bhatti, S. Ali and F. Ahmed, Turk. J. Chem., 30, 193 (2006).